SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Non-Current Liabilities | ₹176 Cr | ₹123 Cr | ₹138 Cr |
What is the latest Total Non-Current Liabilities ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹176 Cr |
| Mar2024 | ₹123 Cr |
| Mar2023 | ₹138 Cr |
How is Total Non-Current Liabilities of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹176 Cr | 43.07 | |
| Mar2024 | ₹123 Cr | -11.15 | |
| Mar2023 | ₹138 Cr | - | |
Compare Total Non-Current Liabilities of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹3,793.4 Cr | -1.7% | -13.2% | -0.7% | Stock Analytics | |
| SAGILITY INDIA | ₹17,718.8 Cr | 0.7% | -19.4% | -9.8% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹16,969.8 Cr | 1.2% | -10.8% | -40.6% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹5,799.1 Cr | -3.3% | -28.7% | -21.7% | Stock Analytics | |
| JUST DIAL | ₹4,435.1 Cr | -2.1% | -24.7% | -38% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹1,930.5 Cr | 7.2% | -27% | -56.8% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -1.7% |
-13.2% |
-0.7% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses